SCHEMBL17875874

SCHEMBL17875874

c1ccc(-c2cc(-c3ccc4c(c3)COCc3ccc(-c5ccc6oc7ccccc7c6c5)cc3-4)cc(-c3ccccc3)n2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 3/20 0.34
PLA2G4A P47712 3/20 0.34
MAPK1 P28482 2/20 0.34
KMT2A Q03164 2/20 0.34
MAPT P10636 4/20 0.33
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 3/20 0.33
HPGD P15428 3/20 0.33
PLA2G10 O15496 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HSP90AA1 P07900 2/20 0.33
NPC1 O15118 2/20 0.33
MEN1 O00255 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CHEK2 O96017 1/20 0.32
CASP3 P42574 1/20 0.32
SENP7 Q9BQF6 1/20 0.32
SENP6 Q9GZR1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875840 1.00 PLA2G2A (0.34) PLA2G2APLA2G4AMAPK1KMT2AMAPT
SCHEMBL17875914 0.96 PLA2G2A (0.37) PLA2G2APLA2G4AMAPK1KMT2AMAPT
SCHEMBL17875836 0.94 HCRTR1 (0.34) PLA2G2APLA2G4AMAPK1KMT2AMAPT
SCHEMBL17875873 0.94 HCRTR1 (0.34) PLA2G2APLA2G4AMAPK1KMT2AMAPT
SCHEMBL17875841 0.90 PLA2G2A (0.40) PLA2G2APLA2G4AKMT2AMAPTKDM4E
SCHEMBL17875857 0.90 PLA2G2A (0.40) PLA2G2APLA2G4AKMT2AMAPTKDM4E
SCHEMBL17875897 0.89 HCRTR1 (0.36) PLA2G2APLA2G4AMAPK1KMT2AMAPT
SCHEMBL17875872 0.89 HSP90AA1 (0.38) MAPK1MAPTKDM4EALDH1A1HPGD
SCHEMBL17875853 0.89 HSP90AA1 (0.38) MAPK1MAPTKDM4EALDH1A1HPGD
SCHEMBL17875838 0.89 MAPT (0.41) PLA2G2APLA2G4AKMT2AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 PLA2G2A 4359/4885PLA2G4A 4087/4885MAPK1 1578/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 PLA2G2A 4359/4885PLA2G4A 4087/4885MAPK1 1578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.